 FREMONT, CA, Aug. 30, 2021 GLOBE NEWSWIRE -- via NewMediaWire ABVC BioPharma, Inc. NASDAQ: ABVC, a clinical stage biopharmaceutical company developing therapeutic solutions in oncologyhematology, CNS, and ophthalmology, today announced that Zacks Small Cap Research has issued an update report on the company which may be accessed at: 